Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study
Articolo
Data di Pubblicazione:
2018
Abstract:
Lymphoproliferative disorders are often observed in HIV-positive patients. Combination antiretroviral treatment (cART) during antineoplastic chemotherapy is beneficial, but little is known about the clinical outcome according to different antiretroviral combinations. The aim of the study was to address this gap in current knowledge.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
HIV; drug-to-drug interactions; lymphoma; protease inhibitors; toxicity
Elenco autori:
Focà, E; Cavaglià, G; Rusconi, Stefano; Cascavilla, A; Cenderello, G; Re, A; Casari, S; van den Bogaart, L; Zinzani, P L; Caracciolo, D; Di Perri, G; Bonito, A; Lucchini, A; Cassola, G; Viale, P; Calcagno, A
Link alla scheda completa:
Pubblicato in: